Life Sciences

HCP/HCO master data that satisfies both commercial teams and regulators

Overview

In pharma, biotech, and medtech, inaccurate HCP and HCO data doesn't just hurt sales force effectiveness — it creates regulatory exposure. When your CRM says one thing, your compliance system says another, and your affiliate data is two years stale, every downstream process suffers. Datagist has implemented Reltio party MDM in life sciences contexts where a single mismatched provider record can trigger an audit finding. We understand the data, the regulations, and the Reltio configuration patterns that make it work.

Key data challenges

×HCP and HCO records fragmented across 10+ CRM and affiliate systems with no single source of truth
×Regulatory submissions requiring complete, auditable data lineage that current systems can't produce
×Drug supply chain traceability mandates under DSCSA and EU FMD with gaps in serialization data
×Field team productivity declining because CRM contact data is stale, duplicate-ridden, or incomplete
×License and credential verification lagging behind state board updates, creating compliance risk
×Consent and opt-out data inconsistent across jurisdictions, exposing the organization to privacy enforcement

How Datagist helps

Party MDM unifying healthcare professionals, organizations, and sites into a trusted golden record
Product MDM connecting drug catalog, supply chain, and formulary data across commercial and regulatory systems
Full audit trail implementation with attribute-level lineage for regulatory submissions
Reltio integration with Veeva CRM, IQVIA, OpenData, and specialty commercial platforms
Automated HCP credential and license verification through AgentFlow-triggered enrichment
Privacy-compliant governance framework with jurisdiction-level consent tracking for GDPR and HIPAA

Discuss your Life Sciences data challenge

We understand the nuances of MDM in your industry.

Get in touch →